title: Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administration.
abstract: For therapeutic monitoring of antiepileptic drugs (AEDs), morning trough levels (MTLs) are generally used. For specific questions like verification of breakthrough seizures or reported toxicity, however, other measures such as minimal and maximal concentrations (C(min), C(max)) can be important and may require daily profiles. For clinical reasons, 20 daily profiles of lamotrigine (LTG) plasma levels were determined in nine patients. The results revealed fluctuations exceeding those expected from its elimination half-life (t(1/2)) of 22h as reported in the literature. Patients on twice-daily regimens without pharmacokinetic interactions exhibited C(min)/C(max) ratios between 0.62 and 0.69. Fluctuations were smaller in those co-medicated with valproate, and reached a ratio of 0.55 in those co-medicated with phenobarbital. The C(max) was as much as 58% above the MTL. Therefore, verification of complaints indicating toxicity requires determination of drug levels when the symptoms are present. Our findings indicate that the t(1/2) of LTG with chronic treatment is shorter than generally assumed, and suggest that a slow-release formulation could be helpful in achieving full seizure control in patients with a narrow individual therapeutic index for LTG.
authors.affiliation: Danish Epilepsy Centre, Dianalund, Denmark.
authors.forename: Kirsten A
authors.initials: KA
authors.lastname: Nielsen
authors.forename: Marit
authors.initials: M
authors.lastname: Dahl
authors.forename: Erling
authors.initials: E
authors.lastname: Tømmerup
authors.forename: Bjarke á Rogvi
authors.initials: Bá
authors.lastname: Hansen
authors.forename: Jesper
authors.initials: J
authors.lastname: Erdal
authors.forename: Peter
authors.initials: P
authors.lastname: Wolf
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000097:blood* / Q000145:classification / Q000493:pharmacokinetics*; D002940:Circadian Rhythm / Q000502:physiology*; D004334:Drug Administration Schedule; D004339:Drug Compounding; D004347:Drug Interactions / Q000502:physiology; D004827:Epilepsy / Q000097:blood* / Q000188:drug therapy; D005260:Female; D006207:Half-Life; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008875:Middle Aged; D014227:Triazines / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics*
chemical_list: D000927:Anticonvulsants; D014227:Triazines; D000077213:Lamotrigine